Point72 Hong Kong LTD Nektar Therapeutics Transaction History

Point72 Hong Kong LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $9,171 - $15,507	3,017 New	3,017 $10,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $56,835 - $96,615	-5,248 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $138,555 - $199,722	-10,601 Reduced 66.89%	5,248 $94,000
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $261,825 - $323,319	15,849 New	15,849 $272,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $2,252 - $3,462	-136 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $2,144 - $2,588	136 New	136 $2,000
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $350,563 - $523,837	-21,131 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $356,268 - $495,310	21,131 New	21,131 $489,000
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $114,613 - $166,972	-7,222 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $122,124 - $261,941	7,222 New	7,222 $132,000
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $6,758 - $7,913	-218 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $6,884 - $10,104	218 New	218 $7,000
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $4,868 - $9,064	-160 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $7,433 - $10,958	160 New	160 $10,000
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $9,065 - $20,472	-196 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $11,250 - $21,254	196 New	196 $21,000

152

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.